Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
buprenorphine (1 trial)
naltrexone (revia) (1 trial)
Opioid-Related Disorders (Phase 2)
Substance-Related Disorders (Phase 2)
Trials (1 total)
Trial APIs (2 total)